BioCentury
ARTICLE | Financial News

Progenics raises $37.4 million in follow-on

June 21, 2013 12:48 AM UTC

Progenics Pharmaceuticals Inc. (NASDAQ:PGNX) raised $37.4 million through the sale of 8.5 million shares at $4.40 in a follow-on underwritten by Jefferies; Needham; Stifel; and Brean Capital. Progenics proposed the offering late Wednesday, when its share price was $4.80. Progenics was down $0.52 (11%) to $4.28 on Thursday. ...